Azenta, Inc.
Azenta, Inc. (AZTA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
azta · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Azenta, Inc. (AZTA) measures how much investors pay for each dollar of the company's trailing earnings. AZTA's current PE ratio of N/A is calculated by dividing its stock price of $22.76 by its TTM earnings per share of -$3.87.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 12 fiscal years · Front-end computedMinQ1 · 25%35.1x
MedianQ3 · 75%157.0x
Max
At N/A, AZTA's current P/E is lower than in 0% of its annual fiscal year readings over the past 12 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Azenta, Inc.You AZTA | $1.0B | N/A | — | -$3.87 |
 BioLife Solutions, Inc. BLFS | $1.3B | N/A | — | -$0.25 |
 Establishment Labs Holdings Inc. ESTA | $2.2B | N/A | — | -$1.72 |
 Evotec SE EVO | $998M | N/A | — | -$0.28 |
 Kestra Medical Technologies, Ltd. KMTS | $1.2B | N/A | — | -$2.30 |
 Neogen Corporation NEOG | $1.9B | N/A | — | -$5.03 |
 NovoCure Limited NVCR | $2.0B | N/A | — | -$1.22 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-1.22 | — | |
2024-09-30 FY2024 | — | $-3.10 | — | |
2023-09-30 FY2023 | — | $-0.22 | — | |
2022-09-30 FY2022 | — | $-5.73 | — | |
2021-09-30 FY2021 | 68.60x | $1.49 | +30.7% | |
2020-09-30 FY2020 | 52.47x | $0.88 | -43.3% | |
2019-09-30 FY2019 | 92.51x | $0.40 | +343.9% | |
2018-09-30 FY2018 | 20.84x | $1.65 | -38.2% | |
2017-09-30 FY2017 | 33.74x | $0.90 | — | |
2016-09-30 FY2016 | — | $-1.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Azenta, Inc. (AZTA) measures how much investors pay for each dollar of the company's trailing earnings. AZTA's current PE ratio of N/A is calculated by dividing its stock price of $22.76 by its TTM earnings per share of -$3.87.
Frequently asked questions
AZTA pe ratio · 6 questionsAZTA's current PE ratio is N/A as of 2026-06-08, based on a stock price of $22.76 and TTM EPS of -$3.87. Data sourced from Financial Modeling Prep via AZTA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Azenta, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08